When stratified by stage, a trend toward a higher frequency of PIK3CA mutations was observed in patients with advanced-stage disease (P=0.0575), although this difference did not reach statistical significance.
← all excerpts
Clinicopathological characterization of cervical squamous cell carcinoma with <i>PIK3CA</i> hotspot mutation: A single-institution study.
1
—
—